Nonmalignant late effects after allogeneic stem cell transplantation.
about
The current status of evidence for and against postnatal oogenesis in mammals: a case of ovarian optimism versus pessimism?Stem cell therapy to cure type 1 diabetes: from hype to hope.Delivering care to long-term adult survivors of hematopoietic cell transplantation.Fertility issues following hematopoietic stem cell transplantationGonadal dysfunction and fertility problems in cancer survivorsWhere are oncofertility and fertility preservation treatments heading in 2016?Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases.Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature.Young adult donor bone marrow infusions into female mice postpone age-related reproductive failure and improve offspring survival.Long-term consequences of hematopoietic stem cell transplantation: current state of the science.Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concernsLiver iron content determination by magnetic resonance imaging.Current practice in total-body irradiation: results of a Canada-wide surveyPulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantationHigh levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Growth impairment after TBI of leukemia survivors children: a model- based investigation.How I treat late effects in adults after allogeneic stem cell transplantation.Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivorsFollow-up care for cancer survivors: the views of clinicians.Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemiaLong-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challengesAdverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.Gallstones in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationResponse to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivorsNonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantationSuccessful Pregnancy and Delivery After Radiation With Ovarian Shielding for Acute Lymphocytic Leukemia Before MenarcheScientific and clinical opportunities for modeling blood disorders with embryonic stem cellsImpact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.The hope and the reality of reduced intensity transplants in children with malignant diseases.Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.Interleukin-1 polymorphisms and graft-vs-host disease.
P2860
Q24647907-021FA180-0403-4961-98A6-7C9BB7F7C0FEQ26823294-E60D0F4D-74AD-40ED-8641-86594BFB01EEQ27021501-8B9F5756-D8FD-484B-BCEA-D6228DED6D9CQ28297647-40D27815-7012-4C00-BB91-9AB1110D75AFQ28301992-C61E7323-744C-4444-97B6-B01328F57CDCQ30249457-BC113A6A-6830-4212-AA09-62EAAE8ED736Q30401036-A81CA1A9-4EEA-4FA1-A8F1-209CB94F15CEQ31109018-7BC879F6-6A0A-4A6B-BB10-8432238F30AEQ33627975-EE4DFA28-296F-472B-A276-C459AAE5B9F5Q33705877-72E9313F-A4A4-48DF-92FD-9D576351FC89Q33754654-D76D47DC-8D94-4942-AC77-E416A2E256CAQ33764777-A815D617-1142-40FF-8239-16681448328DQ33840145-B5C21F68-5728-4B59-8F75-AA732FE2F512Q34058786-E79A18AB-ED4D-4A29-8E51-D1AE818A18C8Q34135089-A4CA34B3-C236-401F-BC76-8E53E0CE8713Q34369800-7944E19F-BE0E-4576-B0D3-C9753BA4413BQ34422867-5E1496F8-42DF-498C-9E23-047958EF878FQ34707208-1156E854-C291-4421-BAC5-3D9DC1EF5288Q34711338-FAA0452B-24DA-4457-B2BF-C577810AA867Q34994605-32D09428-8D55-4F10-B4E1-4F10BF206DFBQ35110623-3C130010-53E0-49A1-896E-AA2A2510CD26Q35153809-DD53F733-9558-4D87-A54B-FA2F3BAA5C4EQ35153813-D3699CF0-E345-4DAE-AE0B-FBB175B8E28AQ35184667-850BF384-BE87-4D9B-A21F-F95A71DF19F1Q35223947-7D6D2641-F541-4BC3-AE07-B30A874293A0Q35525461-256DAE48-DD08-445A-AA1A-FE593A005523Q35563274-6D7B7B75-0A06-421B-A81D-5CF62C44C316Q35571058-A011F541-C096-473A-88C5-74D74C74CA02Q35600025-FF312187-98A5-4EAE-BCCB-DE974F3CDC41Q35613207-00543F7C-31E4-45DD-850B-F88D6EFF772DQ35623591-3F7727AA-E34D-4C72-A34F-E2A7BB057878Q35628840-D99B23BE-6060-433B-9245-D6CDC8FFC3D5Q35661304-54DFC159-E7DF-4914-9BDF-7DFEC21E8D8AQ35665096-EF7FFD81-AF54-4AC4-AD9C-3EC999A23D83Q35755639-E897CC6E-6A86-4086-A14F-D4C267790ECAQ35848553-F0AFBEC6-E420-405F-B32B-5F47E712F850Q35849241-AEF5B846-41D1-4AF3-A5F1-98B85F5E2E21Q36090213-2A51FD1D-4D52-46BB-A827-F8B1B62AA08DQ36169872-EC34A778-4F6F-4366-ABE5-0C6DABE3E0EAQ36194613-FD4FA0DE-62D9-4E64-8AEA-0B185FF9D530
P2860
Nonmalignant late effects after allogeneic stem cell transplantation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Nonmalignant late effects after allogeneic stem cell transplantation.
@ast
Nonmalignant late effects after allogeneic stem cell transplantation.
@en
type
label
Nonmalignant late effects after allogeneic stem cell transplantation.
@ast
Nonmalignant late effects after allogeneic stem cell transplantation.
@en
prefLabel
Nonmalignant late effects after allogeneic stem cell transplantation.
@ast
Nonmalignant late effects after allogeneic stem cell transplantation.
@en
P2093
P1433
P1476
Nonmalignant late effects after allogeneic stem cell transplantation.
@en
P2093
Amnon Cohen
André Tichelli
Anna Locasciulli
Attilio Rovelli
Elisabeth Korthof
Enric Carreras
Joachim Weis
Late Effects Working Party of ...... ood and Marrow Transplantation
Nina Salooja
Vincent Levy
P304
P356
10.1182/BLOOD-2002-07-2231
P407
P50
P577
2003-01-02T00:00:00Z